These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 369621)

  • 1. [Nature of the intermediate compound formed during catalysis by pepsin].
    Kozlov LV
    Biokhimiia; 1979 Jan; 44(1):172-6. PubMed ID: 369621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enzyme intermediates with the C-terminal products of substrate hydrolysis by carboxypeptidase A and chymotrypsin. Use of the free energy linearity principle].
    Kozlov LV
    Biokhimiia; 1980 Aug; 45(8):1442-7. PubMed ID: 7236796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Principle of free energies linearity in chymotrypsin catalysis].
    Kozlov LV
    Biokhimiia; 1979 Jan; 44(1):166-71. PubMed ID: 33727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Free energy linearity principle in enzymatic catalysis and thermodynamic principles of specificity].
    Kozlov LV
    Biokhimiia; 1981 Aug; 46(8):1369-75. PubMed ID: 7272358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR study of the inhibition of pepsin by glyoxal inhibitors: mechanism of tetrahedral intermediate stabilization by the aspartyl proteases.
    Cosgrove S; Rogers L; Hewage CM; Malthouse JP
    Biochemistry; 2007 Oct; 46(39):11205-15. PubMed ID: 17824620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of oxygen exchange in the amide group of substrates during their hydrolysis catalyzed by leucine aminopeptidase and pepsin].
    Kapitannikov IuV; Iavashev LP; Ginodman LM; Antonov VK
    Bioorg Khim; 1983 Feb; 9(2):228-31. PubMed ID: 6435638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Tyr13 and Phe219 in the unique substrate specificity of pepsin B.
    Kageyama T
    Biochemistry; 2006 Dec; 45(48):14415-26. PubMed ID: 17128981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and kinetic studies on native intermediates and an intermediate analogue in benzoylformate decarboxylase reveal a least motion mechanism with an unprecedented short-lived predecarboxylation intermediate.
    Bruning M; Berheide M; Meyer D; Golbik R; Bartunik H; Liese A; Tittmann K
    Biochemistry; 2009 Apr; 48(15):3258-68. PubMed ID: 19182954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The reaction of pepsin and pepsinogen with dicyclohexylcarbodiimide].
    Gorodetskii DI; Miasoedov NF; Stepanov VM
    Biokhimiia; 1975; 40(6):1305-10. PubMed ID: 764886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries.
    Sauve AA; Munshi C; Lee HC; Schramm VL
    Biochemistry; 1998 Sep; 37(38):13239-49. PubMed ID: 9748331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New data on pepsin mechanism and specificity.
    Antonov VK
    Adv Exp Med Biol; 1977; 95():179-98. PubMed ID: 339689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The electrostatic driving force for nucleophilic catalysis in L-arginine deiminase: a combined experimental and theoretical study.
    Li L; Li Z; Wang C; Xu D; Mariano PS; Guo H; Dunaway-Mariano D
    Biochemistry; 2008 Apr; 47(16):4721-32. PubMed ID: 18366187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of pepsin-catalysed transpeptidation: evidence for the 'amino-enzyme' intermediate.
    Antonov VK; Rumsh LD; Tikhodeeva AG
    FEBS Lett; 1974 Sep; 46(1):29-33. PubMed ID: 4609205
    [No Abstract]   [Full Text] [Related]  

  • 14. Substrate binding mechanism of Glu180-->Gln, Asp176-->Asn, and wild-type glucoamylases from Aspergillus niger.
    Christensen U; Olsen K; Stoffer BB; Svensson B
    Biochemistry; 1996 Nov; 35(47):15009-18. PubMed ID: 8942667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3.
    Ng KK; Petersen JF; Cherney MM; Garen C; Zalatoris JJ; Rao-Naik C; Dunn BM; Martzen MR; Peanasky RJ; James MN
    Nat Struct Biol; 2000 Aug; 7(8):653-7. PubMed ID: 10932249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based inactivation of mouse hepatic cytochrome P4502B enzymes by amine metabolites of musk xylene.
    Lehman-McKeeman LD; Johnson DR; Caudill D; Stuard SB
    Drug Metab Dispos; 1997 Mar; 25(3):384-9. PubMed ID: 9172959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalysis and function of the p38 alpha.MK2a signaling complex.
    Lukas SM; Kroe RR; Wildeson J; Peet GW; Frego L; Davidson W; Ingraham RH; Pargellis CA; Labadia ME; Werneburg BG
    Biochemistry; 2004 Aug; 43(31):9950-60. PubMed ID: 15287722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The strength of dehalogenase-substrate hydrogen bonding correlates with the rate of Meisenheimer intermediate formation.
    Dong J; Lu X; Wei Y; Luo L; Dunaway-Mariano D; Carey PR
    Biochemistry; 2003 Aug; 42(31):9482-90. PubMed ID: 12899635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The ability of pepsin to form a covalent compound with substrate fragment (reaction product)].
    Ginodman LM; Lutsenko NG; Barshevskaia TN; Somova VV
    Biokhimiia; 1971; 36(3):604-14. PubMed ID: 4943651
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of pulsed electric fields on the activity and structure of pepsin.
    Yang R; Li SQ; Zhang QH
    J Agric Food Chem; 2004 Dec; 52(24):7400-6. PubMed ID: 15563226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.